(Bloomberg) Hedge fund Sparrow Fund Management LP said in a lawsuit it was falsely accused by MiMedx Group Inc. of trying to illegally manipulate the biotech firm’s stock price.
Hedge Fund Sues MiMedx Over Short-Selling Claims
This entry was posted in Syndicated. Bookmark the permalink.
